Emerging diagnostic and therapeutic options for treating mucormycosis

References

• Petrikkos G, Skiada A, Lortholary O, et al. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012;54(Suppl 1):S23–S34.
   PubMed Web of Science ®Google Scholar
• Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev. 2000;13(2):236–301.
   PubMed Web of Science ®Google Scholar
• Kauffman CA, Malani AN. Zygomycosis: an emerging fungal infection with new options for management. Curr Infect Dis Rep. 2007;9(6):435–440.
   PubMedGoogle Scholar
• Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634–653.
   PubMed Web of Science ®Google Scholar
• Shoham S, Magill SS, Merz WG, et al. Primary treatment of zygomycosis with liposomal amphotericin B: analysis of 28 cases. Med Mycol. 2010;48(3):511–517.
   PubMed Web of Science ®Google Scholar
• Neblett Fanfair R, Benedict K, Bos J, et al. Necrotizing cutaneous mucormycosis after a tornado in Joplin, Missouri, in 2011. N Engl J Med. 2012;367(23):2214–2225.
   PubMed Web of Science ®Google Scholar
• Warwar RE, Bullock JD. Rhino-orbital-cerebral mucormycosis: a review. Orbit. 1998;17(4):237–245.
   PubMedGoogle Scholar
• Pyrgos V, Shoham S, Walsh TJ. Pulmonary zygomycosis. Semin Respir Crit Care Med. 2008;29(2):111–120.
   PubMed Web of Science ®Google Scholar
• Rupp ME. Images in clinical medicine. Rhinocerebral mucormycosis. N Engl J Med. 1995;333(9):564.
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Gamaletsou MN, McGinnis MR, et al. Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis). Clin Infect Dis. 2012;54(Suppl 1):S55–S60.
   PubMed Web of Science ®Google Scholar
• Lass-Flörl C. Zygomycosis: conventional laboratory diagnosis. Clin Microbiol Infect. 2009;15(Suppl 5):60–65.
   PubMed Web of Science ®Google Scholar
• Machouart M, Larché J, Burton K, et al. Genetic identification of the main opportunistic Mucorales by PCR-restriction fragment length polymorphism. J Clin Microbiol. 2006;44(3):805–810.
   PubMed Web of Science ®Google Scholar
• Hammond SP, Bialek R, Milner DA, et al. Molecular methods to improve diagnosis and identification of mucormycosis. J Clin Microbiol. 2011;49(6):2151–2153.
   PubMed Web of Science ®Google Scholar
• Kasai M, Harrington SM, Francesconi A, et al. Detection of a molecular biomarker for zygomycetes by quantitative PCR assays of plasma, bronchoalveolar lavage, and lung tissue in a rabbit model of experimental pulmonary zygomycosis. J Clin Microbiol. 2008;46(11):3690–3702.
   PubMed Web of Science ®Google Scholar
• Millon L, Larosa F, Lepiller Q, et al. Quantitative polymerase chain reaction detection of circulating DNA in serum for early diagnosis of mucormycosis in immunocompromised patients. Clin Infect Dis. 2013;56(10):e95–e101.
   PubMed Web of Science ®Google Scholar
• Buelow DR, Gu Z, Walsh TJ, et al. Evaluation of multiplexed PCR and liquid-phase array for identification of respiratory fungal pathogens. Med Mycol. 2012;50(7):775–780.
   PubMed Web of Science ®Google Scholar
• Massire C, Buelow DR, Zhang SX, et al. PCR followed by electrospray ionization mass spectrometry for broad-range identification of fungal pathogens. J Clin Microbiol. 2013;51(3):959–966.
   PubMed Web of Science ®Google Scholar
• Lewis RE, Lortholary O, Spellberg B, et al. How does antifungal pharmacology differ for mucormycosis versus aspergillosis? Clin Infect Dis. 2012;54(Suppl 1):S67–S72.
   PubMed Web of Science ®Google Scholar
• Spellberg B, Ibrahim A, Roilides E, et al. Combination therapy for mucormycosis: why, what, and how? Clin Infect Dis. 2012;54(Suppl 1):S73–S78.
   PubMed Web of Science ®Google Scholar
• Cornely OA, Arikan-Akdagli S, Dannaoui E, et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect. 2014;20(Suppl 3):5–26.
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Skiada A, Cornely OA, et al. Development of new strategies for early diagnosis of mucormycosis from bench to bedside. Mycoses. 2014;57(Suppl 3):2–7.
   PubMed Web of Science ®Google Scholar
• Gomes MZ, Lewis RE, Kontoyiannis DP. Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species. Clin Microbiol Rev. 2011;24(2):411–445.
   PubMed Web of Science ®Google Scholar
• Singh P, Paul S, Shivaprakash MR, et al. Stress response in medically important Mucorales. Mycoses. 2016;59:628–635.
   Web of Science ®Google Scholar
• Mahmud A, Lee R, Munfus-McCray D, et al. Actinomucor elegans as an emerging cause of Mucormycosis. J Clin Microbiol. 2012;50(3):1092–1095.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Gutiérrez G, Carrillo-Casas EM, Arenas R, et al. Mucormycosis in a Non-Hodgkin Lymphoma patient caused by Syncephalastrum racemosum: case report and review of literature. Mycopathologia. 2015;180(1–2):89–93.
   PubMed Web of Science ®Google Scholar
• Spellberg B, Ibrahim AS. Recent advances in the treatment of mucormycosis. Curr Infect Dis Rep. 2010;12(6):423–429.
   PubMedGoogle Scholar
• Chamilos G, Marom EM, Lewis RE, et al. Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer. Clin Infect Dis. 2005;41(1):60–66.
   PubMed Web of Science ®Google Scholar
• McCarthy M, Rosengart A, Schuetz AN, et al. Mold infections of the central nervous system. N Engl J Med. 2014;371(2):150–160.
   PubMed Web of Science ®Google Scholar
• Spellberg B, Walsh TJ, Kontoyiannis DP, et al. Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis. 2009;48(12):1743–1751.
   PubMed Web of Science ®Google Scholar
• Wahba H, Truong MT, Lei X, et al. Reversed halo sign in invasive pulmonary fungal infections. Clin Infect Dis. 2008;46(11):1733–1737.
   PubMed Web of Science ®Google Scholar
• Kedziora KM, Jalink K. Fluorescence resonance energy transfer microscopy (FRET). Methods Mol Biol. 2015;1251:67–82.
   PubMedGoogle Scholar
• Ecker RC, de Martin R, Steiner GE, et al. Application of spectral imaging microscopy in cytomics and fluorescence resonance energy transfer (FRET) analysis. Cytometry A. 2004;59(2):172–181.
   PubMed Web of Science ®Google Scholar
• Francesconi A, Kasai M, Harrington SM, et al. Automated and manual methods of DNA extraction for Aspergillus fumigatus and Rhizopus oryzae analyzed by quantitative real-time PCR. J Clin Microbiol. 2008;46(6):1978–1984.
   PubMed Web of Science ®Google Scholar
• Sandhu GS, Kline BC, Stockman L, et al. Molecular probes for diagnosis of fungal infections. J Clin Microbiol. 1995;33(11):2913–2919.
   PubMed Web of Science ®Google Scholar
• Hata DJ, Buckwalter SP, Pritt BS, et al. Real-time PCR method for detection of zygomycetes. J Clin Microbiol. 2008;46(7):2353–2358.
   PubMed Web of Science ®Google Scholar
• Dannaoui E, Meletiadis J, Mouton JW, et al. In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother. 2003;51(1):45–52.
   PubMed Web of Science ®Google Scholar
• Rickerts V, Just-Nübling G, Konrad F, et al. Diagnosis of invasive aspergillosis and mucormycosis in immunocompromised patients by seminested PCR assay of tissue samples. Eur J Clin Microbiol Infect Dis. 2006;25(1):8–13.
   PubMed Web of Science ®Google Scholar
• Nagao K, Ota T, Tanikawa A, et al. Genetic identification and detection of human pathogenic Rhizopus species, a major mucormycosis agent, by multiplex PCR based on internal transcribed spacer region of rRNA gene. J Dermatol Sci. 2005;39(1):23–31.
   PubMed Web of Science ®Google Scholar
• Bernal-Martínez L, Buitrago MJ, Castelli MV, et al. Development of a single tube multiplex real-time PCR to detect the most clinically relevant Mucormycetes species. Clin Microbiol Infect. 2013;19(1):E1–E7.
   PubMed Web of Science ®Google Scholar
• Pemov A, Modi H, Chandler DP, et al. DNA analysis with multiplex microarray-enhanced PCR. Nucleic Acids Res. 2005;33(2):e11.
   PubMed Web of Science ®Google Scholar
• Hong BX, Jiang LF, Hu YS, et al. Application of oligonucleotide array technology for the rapid detection of pathogenic bacteria of foodborne infections. J Microbiol Methods. 2004;58(3):403–411.
   PubMed Web of Science ®Google Scholar
• Leinberger DM, Schumacher U, Autenrieth IB, et al. Development of a DNA microarray for detection and identification of fungal pathogens involved in invasive mycoses. J Clin Microbiol. 2005;43(10):4943–4953.
   PubMed Web of Science ®Google Scholar
• Spiess B, Seifarth W, Hummel M, et al. DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients. J Clin Microbiol. 2007;45(11):3743–3753.
   PubMed Web of Science ®Google Scholar
• Barnes RA. Early diagnosis of fungal infection in immunocompromised patients. J Antimicrob Chemother. 2008;61(Suppl 1):i3–i6.
   PubMed Web of Science ®Google Scholar
• Rampini SK, Zbinden A, Speck RF, et al. Similar efficacy of broad-range ITS PCR and conventional fungal culture for diagnosing fungal infections in non-immunocompromised patients. BMC Microbiol. 2016;16(1):132.
   PubMed Web of Science ®Google Scholar
• Katz LA. Changing perspectives on the origin of eukaryotes. Trends Ecol Evol. 1998;13(12):493–497.
   PubMed Web of Science ®Google Scholar
• Scherer LC, Sperhacke RD, Ruffino-Netto A, et al. Cost-effectiveness analysis of PCR for the rapid diagnosis of pulmonary tuberculosis. BMC Infect Dis. 2009;9:216.
   PubMed Web of Science ®Google Scholar
• Venter JC, Remington K, Heidelberg JF, et al. Environmental genome shotgun sequencing of the Sargasso Sea. Science. 2004;304(5667):66–74.
   PubMed Web of Science ®Google Scholar
• Haas BJ, Gevers D, Earl AM, et al. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res. 2011;21(3):494–504.
   PubMed Web of Science ®Google Scholar
• Chandler JA, Liu RM, Bennett SN. RNA shotgun metagenomic sequencing of northern California (USA) mosquitoes uncovers viruses, bacteria, and fungi. Front Microbiol. 2015;6:185.
   PubMed Web of Science ®Google Scholar
• Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59–65.
   PubMed Web of Science ®Google Scholar
• Shelburne SA, Ajami NJ, Chibucos MC, et al. Implementation of a pan-genomic approach to investigate holobiont-infecting microbe interaction: a case report of a leukemic patient with invasive mucormycosis. PLoS One. 2015;10(11):e0139851.
   PubMed Web of Science ®Google Scholar
• Yaman G, Akyar I, Can S. Evaluation of the MALDI TOF-MS method for identification of Candida strains isolated from blood cultures. Diagn Microbiol Infect Dis. 2012;73(1):65–67.
   PubMed Web of Science ®Google Scholar
• Lay JO. MALDI-TOF mass spectrometry of bacteria. Mass Spectrom Rev. 2001;20(4):172–194.
   PubMed Web of Science ®Google Scholar
• Dolatabadi S, Kolecka A, Versteeg M, et al. Differentiation of clinically relevant Mucorales Rhizopus microsporus and R. arrhizus by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). J Med Microbiol. 2015;64(7):694–701.
   PubMed Web of Science ®Google Scholar
• Schrödl W, Heydel T, Schwartze VU, et al. Direct analysis and identification of pathogenic Lichtheimia species by matrix-assisted laser desorption ionization-time of flight analyzer-mediated mass spectrometry. J Clin Microbiol. 2012;50(2):419–427.
   PubMed Web of Science ®Google Scholar
• Mery A, Sendid B, François N, et al. Application of mass spectrometry technology to the early diagnosis of invasive fungal infections. J Clin Microbiol. 2016;54:2786–2797.
   PubMed Web of Science ®Google Scholar
• Badior M, Trigo F, Eloy C, et al. Mucor infection: difficult diagnosis. Clin Drug Investig. 2013;33(Suppl 1):S19–21.
   PubMed Web of Science ®Google Scholar
• Spellberg B, Kontoyiannis DP, Fredricks D, et al. Risk factors for mortality in patients with mucormycosis. Med Mycol. 2012;50(6):611–618.
   PubMed Web of Science ®Google Scholar
• Chitasombat MN, Kontoyiannis DP. Treatment of mucormycosis in transplant patients: role of surgery and of old and new antifungal agents. Curr Opin Infect Dis. 2016;29(4):340–345.
   PubMed Web of Science ®Google Scholar
• Palejwala SK, Zangeneh TT, Goldstein SA, et al. An aggressive multidisciplinary approach reduces mortality in rhinocerebral mucormycosis. Surg Neurol Int. 2016;7:61.
   PubMedGoogle Scholar
• Wang XM, Guo LC, Xue SL, et al. Pulmonary mucormycosis: a case report and review of the literature. Oncol Lett. 2016;11(5):3049–3053.
   PubMed Web of Science ®Google Scholar
• Tedder M, Spratt JA, Anstadt MP, et al. Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg. 1994;57(4):1044–1050.
   PubMed Web of Science ®Google Scholar
• Sáez I, Chico M, Robles A, et al. [Mucormycosis in severe trauma patients]. Med Intensiva. 2014;38(7):465–466.
   PubMed Web of Science ®Google Scholar
• Patiño JF, Castro D, Valencia A, et al. Necrotizing soft tissue lesions after a volcanic cataclysm. World J Surg. 1991;15(2):240–247.
   PubMed Web of Science ®Google Scholar
• Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis. 2008;47(4):503–509.
   PubMed Web of Science ®Google Scholar
• Barron MA, Lay M, Madinger NE. Surgery and treatment with high-dose liposomal amphotericin B for eradication of craniofacial zygomycosis in a patient with Hodgkin’s disease who had undergone allogeneic hematopoietic stem cell transplantation. J Clin Microbiol. 2005;43(4):2012–2014.
   PubMed Web of Science ®Google Scholar
• Emminger W, Graninger W, Emminger-Schmidmeier W, et al. Tolerance of high doses of amphotericin B by infusion of a liposomal formulation in children with cancer. Ann Hematol. 1994;68(1):27–31.
   PubMed Web of Science ®Google Scholar
• Vehreschild JJ, Birtel A, Vehreschild MJ, et al. Mucormycosis treated with posaconazole: review of 96 case reports. Crit Rev Microbiol. 2013;39(3):310–324.
   PubMed Web of Science ®Google Scholar
• Lanternier F, Dannaoui E, Morizot G, et al. A global analysis of mucormycosis in France: the RetroZygo study (2005-2007). Clin Infect Dis. 2012;54(Suppl 1):S35–S43.
   PubMed Web of Science ®Google Scholar
• Bitar D, Van Cauteren D, Lanternier F, et al. Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006. Emerg Infect Dis. 2009;15(9):1395–1401.
   PubMed Web of Science ®Google Scholar
• Inoue S, Odaka A, Hashimoto D, et al. Rare case of disseminated neonatal zygomycosis mimicking necrotizing enterocolitis with necrotizing fasciitis. J Pediatr Surg. 2011;46(10):E29–E32.
   PubMed Web of Science ®Google Scholar
• Capoor MR, Sarabahi S, Tiwari VK, et al. Fungal infections in burns: diagnosis and management. Indian J Plast Surg. 2010;43(Suppl):S37–S42.
   PubMedGoogle Scholar
• Reyes HM, Tingle EJ, Fenves AZ, et al. Pulmonary invasive mucormycosis in a patient with secondary iron overload following deferoxamine therapy. Proc (Bayl Univ Med Cent). 2008;21(4):378–381.
   PubMedGoogle Scholar
• Pfaller MA, Messer SA, Rhomberg PR, et al. In vitro activities of isavuconazole and comparator antifungal agents tested against a global collection of opportunistic yeasts and molds. J Clin Microbiol. 2013;51(8):2608–2616.
   PubMed Web of Science ®Google Scholar
• Verweij PE, González GM, Wiedrhold NP, et al. In vitro antifungal activity of isavuconazole against 345 mucorales isolates collected at study centers in eight countries. J Chemother. 2009;21(3):272–281.
   PubMed Web of Science ®Google Scholar
• Thompson GR, Wiederhold NP. Isavuconazole: a comprehensive review of spectrum of activity of a new triazole. Mycopathologia. 2010;170(5):291–313.
   PubMed Web of Science ®Google Scholar
• Donnelley MA, Zhu ES, Thompson GR. Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections. Infect Drug Resist. 2016;9:79–86.
   PubMed Web of Science ®Google Scholar
• Marty FM, Ostrosky-Zeichner L, Cornely OA, et al. Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis. Lancet Infect Dis. 2016;16(7):828–837.
   PubMed Web of Science ®Google Scholar
• Luo G, Gebremariam T, Lee H, et al. Isavuconazole therapy protects immunosuppressed mice from mucormycosis. Antimicrob Agents Chemother. 2014;58(4):2450–2453.
   PubMed Web of Science ®Google Scholar
• Arendrup MC, Jensen RH, In Vitro MJ. Activity of isavuconazole and comparators against clinical isolates of the mucorales order. Antimicrob Agents Chemother. 2015;59(12):7735–7742.
   PubMed Web of Science ®Google Scholar
• Kontoyiannis DP, Lewis RE. How I treat mucormycosis. Blood. 2011;118(5):1216–1224.
   PubMed Web of Science ®Google Scholar
• Denning DW, Bromley MJ. Infectious disease. How to bolster the antifungal pipeline. Science. 2015;347(6229):1414–1416.
   PubMed Web of Science ®Google Scholar
• Calderone R, Sun N, Gay-Andrieu F, et al. Antifungal drug discovery: the process and outcomes. Future Microbiol. 2014;9(6):791–805.
   PubMed Web of Science ®Google Scholar
• Ianiri G, Idnurm A. Essential gene discovery in the basidiomycete Cryptococcus neoformans for antifungal drug target prioritization. MBio. 2015;6:2.
   Web of Science ®Google Scholar
• Roemer T, Boone C. Systems-level antimicrobial drug and drug synergy discovery. Nat Chem Biol. 2013;9(4):222–231.
   PubMed Web of Science ®Google Scholar
• Kontoyiannis DP, Lewis RE. Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management. Infect Dis Clin North Am. 2006;20(3):581–607, vi.
   PubMed Web of Science ®Google Scholar
• Vijayabala GS, Annigeri RG, Sudarshan R. Mucormycosis in a diabetic ketoacidosis patient. Asian Pac J Trop Biomed. 2013;3(10):830–833.
   PubMedGoogle Scholar
• Tugsel Z, Sezer B, Akalin T. Facial swelling and palatal ulceration in a diabetic patient. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;98(6):630–636.
   PubMed Web of Science ®Google Scholar
• Gale GR, Welch AM. Studies of opportunistic fungi. I. Inhibition of Rhizopus oryzae by human serum. Am J Med Sci. 1961;241:604–612.
   PubMed Web of Science ®Google Scholar
• Jorens PG, Boelaert JR, Halloy V, et al. Human and rat macrophages mediate fungistatic activity against Rhizopus species differently: in vitro and ex vivo studies. Infect Immun. 1995;63(11):4489–4494.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Crichton RR, Boelaert JR, et al. Decreased release of nitric oxide (NO) by alveolar macrophages after in vivo loading of rats with either iron or ethanol. Biochem Pharmacol. 1998;55(1):21–25.
   PubMed Web of Science ®Google Scholar
• Ibrahim AS, Kontoyiannis DP. Update on mucormycosis pathogenesis. Curr Opin Infect Dis. 2013;26(6):508–515.
   PubMed Web of Science ®Google Scholar
• Berdai MA, Labib S, Harandou M. [Rhinocerebral mucormycosis complicating ketoacidosis diabetes]. Presse Med. 2016;45(1):145–146.
   PubMed Web of Science ®Google Scholar
• McCrory MC, Moore BA, Nakagawa TA, et al. Disseminated mucormycosis in an adolescent with newly diagnosed diabetes mellitus. Pediatr Infect Dis J. 2014;33(10):1094–1096.
   PubMed Web of Science ®Google Scholar
• Boelaert JR, Fenves AZ, Coburn JW. Deferoxamine therapy and mucormycosis in dialysis patients: report of an international registry. Am J Kidney Dis. 1991;18(6):660–667.
   PubMed Web of Science ®Google Scholar
• Ferguson BJ, Mitchell TG, Moon R, et al. Adjunctive hyperbaric oxygen for treatment of rhinocerebral mucormycosis. Rev Infect Dis. 1988;10(3):551–559.
   PubMedGoogle Scholar
• Kajs-Wyllie M. Hyperbaric oxygen therapy for rhinocerebral fungal infection. J Neurosci Nurs. 1995;27(3):174–181.
   PubMedGoogle Scholar
• Gil-Lamaignere C, Simitsopoulou M, Roilides E, et al. Interferon- gamma and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important zygomycetes. J Infect Dis. 2005;191(7):1180–1187.
   PubMed Web of Science ®Google Scholar
• Abzug MJ, Walsh TJ. Interferon-gamma and colony-stimulating factors as adjuvant therapy for refractory fungal infections in children. Pediatr Infect Dis J. 2004;23(8):769–773.
   PubMed Web of Science ®Google Scholar
• Gonzalez CE, Couriel DR, Walsh TJ. Disseminated zygomycosis in a neutropenic patient: successful treatment with amphotericin B lipid complex and granulocyte colony-stimulating factor. Clin Infect Dis. 1997;24(2):192–196.
   PubMed Web of Science ®Google Scholar
• Osherov N, Kontoyiannis DP. The anti-Aspergillus drug pipeline: is the glass half full or empty? Med Mycol. 2016;55:2969–2975.
   PubMed Web of Science ®Google Scholar
• Haug CJ. from patient to patient - sharing the data from clinical trials. N Engl J Med. 2016;25:2409–2411.
   Web of Science ®Google Scholar
• Sussex J, Rollet P, Garau M, et al. A pilot study of multicriteria decision analysis for valuing orphan medicines. Value Health. 2013;16(8):1163–1169.
   PubMed Web of Science ®Google Scholar
• De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46(12):1813–1821.
   PubMed Web of Science ®Google Scholar
• Czurda S, Smelik S, Preuner-Stix S, et al. Occurrence of fungal DNA contamination in PCR reagents: approaches to control and decontamination. J Clin Microbiol. 2016;54(1):148–152.
   PubMed Web of Science ®Google Scholar
• Corless CE, Guiver M, Borrow R, et al. Contamination and sensitivity issues with a real-time universal 16S rRNA PCR. J Clin Microbiol. 2000;38(5):1747–1752.
   PubMed Web of Science ®Google Scholar
• Loeffler J, Hebart H, Bialek R, et al. Contaminations occurring in fungal PCR assays. J Clin Microbiol. 1999;37(4):1200–1202.
   PubMed Web of Science ®Google Scholar
• Champlot S, Berthelot C, Pruvost M, et al. An efficient multistrategy DNA decontamination procedure of PCR reagents for hypersensitive PCR applications. PLoS One. 2010;5:9.
   Web of Science ®Google Scholar
• Neely LA, Audeh M, Phung NA, et al. T2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood. Sci Transl Med. 2013;5(182):182ra54.
   PubMed Web of Science ®Google Scholar
• Järvinen AK, Laakso S, Piiparinen P, et al. Rapid identification of bacterial pathogens using a PCR- and microarray-based assay. BMC Microbiol. 2009;9:161.
   PubMed Web of Science ®Google Scholar
• Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, et al. T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial. Clin Infect Dis. 2015;60(6):892–899.
   PubMed Web of Science ®Google Scholar
• Boch T, Reinwald M, Postina P, et al. Identification of invasive fungal diseases in immunocompromised patients by combining an Aspergillus specific PCR with a multifungal DNA-microarray from primary clinical samples. Mycoses. 2015;58(12):735–745.
   PubMed Web of Science ®Google Scholar
• Vincent M, Xu Y, Kong H. Helicase-dependent isothermal DNA amplification. EMBO Rep. 2004;5(8):795–800.
   PubMed Web of Science ®Google Scholar
• Gill P, Ghaemi A. Nucleic acid isothermal amplification technologies: a review. Nucleosides Nucleotides Nucleic Acids. 2008;27(3):224–243.
   PubMed Web of Science ®Google Scholar
• Mori Y, Kanda H, Notomi T. Loop-mediated isothermal amplification (LAMP): recent progress in research and development. J Infect Chemother. 2013;19(3):404–411.
   PubMed Web of Science ®Google Scholar
• Uemori T, Mukai H, Takeda O, et al. Investigation of the molecular mechanism of ICAN, a novel gene amplification method. J Biochem. 2007;142(2):283–292.
   PubMed Web of Science ®Google Scholar
• Beattie KD, Ellwood N, Kumar R, et al. Antibacterial and antifungal screening of natural products sourced from Australian fungi and characterisation of pestalactams D-F. Phytochemistry. 2016;124:79–85.
   PubMed Web of Science ®Google Scholar
• Tevyashova AN, Olsufyeva EN, Solovieva SE, et al. Structure-antifungal activity relationships of polyene antibiotics of the amphotericin B group. Antimicrob Agents Chemother. 2013;57(8):3815–3822.
   PubMed Web of Science ®Google Scholar
• Fosso M, AlFindee MN, Zhang Q, et al. Structure-activity relationships for antibacterial to antifungal conversion of kanamycin to amphiphilic analogues. J Org Chem. 2015;80(9):4398–4411.
   PubMed Web of Science ®Google Scholar
• Butts A, Krysan DJ. Antifungal drug discovery: something old and something new. PLoS Pathog. 2012;8(9):e1002870.
   PubMed Web of Science ®Google Scholar